Clinical Trial Update: Combination Chemotherapy in Treating Patients With Multiple Myeloma [Phase 3]

View source ↗

Summary

Phase 3 trial update for combination chemotherapy in treating patients with multiple myeloma and plasma cell neoplasm.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma
• Plasma Cell Neoplasm

Snippet

Sponsor: NCIC Clinical Trials Group | Conditions: Multiple Myeloma and Plasma Cell Neoplasm | Phase 3 | Status: COMPLETED